Z-1670-2021 Class II Terminated

Recalled by Beckman Coulter Inc. — Brea, CA

FDA device recall Z-1670-2021 was initiated by Beckman Coulter Inc. on April 14, 2021 and is designated Class II. Reason for recall: specimens collected in transport media may result is false negative results when stored in certain conditions. The recall status is terminated (terminated May 19, 2023). Affected quantity: 1,034 units.

Recall Details

Product Type
Devices
Report Date
June 2, 2021
Initiation Date
April 14, 2021
Termination Date
May 19, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
1,034 units

Product Description

Access SARS-CoV-2 Antigen, REF C68668, UDI: (01)15099590742713, 3.30 mL/R1a, 4.70 mL/R1b, 4.20 mL/R1c, 3.10 mL, R1d, 3.10 mL, R1e

Reason for Recall

specimens collected in transport media may result is false negative results when stored in certain conditions.

Distribution Pattern

Worldwide distribution - US Nationwide distribution in the states of Alabama, Arizona, Arkansas, California, Connecticut, Delaware, Florida, Georgia, Idaho, Illinois, Indiana, Iowa, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Mississippi, New Hampshire, New Jersey, New York, North Carolina, Ohio, Oklahoma, Oregon, Pennsylvania, Puerto Rico, Tennessee, Texas, Virginia, West Virginia and the country of New Zealand.

Code Information

All Lots